|
[1]Baffy G.Kupffer cells in non-alcoholic fatty liver disease:Theemerging view[J].J Hepatol, 2009, 51 (1) :212-223.
|
|
[2]Gao B, Radaeva S, Park O.Liver natural killer and natural kil-ler T cells:immunobiology and emerging roles in liver disea-ses[J].J Leukoc Biol, 2009, 86 (3) :513-528.
|
|
[3]Miura K, Seki E, Ohnishi H, et al.Role of Toll-Like recep-tors and their downstream molecules in the development ofnonalcoholic fatty liver disease[J].Gastroenterol Res Pract, 2010, 2010:362847.
|
|
[4]Zhan YT, An W.Roles of liver innate immune cells in nonal-coholic fatty liver disease[J].World J Gastroenterol, 2010, 16 (37) :4652-4660.
|
|
[5]Koek GH, Liedorp PR, Bast A.The role of oxidative stress innon-alcoholic steatohepatitis[J].Clin Chim Acta, 2011, 412:1297-1305.
|
|
[6]Otagawa K, inoshita K, Fujii H, et al.Erythrophagocytosis byliver macrophages (Kupffer cells) promote oxidative stress, inflammation, and fibrosis in a rabbit model of steatohepatitis[J].Am J Pathol, 2007, 170 (3) :967-980.
|
|
[7]CaniPD, Amar J, Iglesias MA, et al.Metabolic endotoxemiainitiates obesity and Insulin resistance[J].Diabetes, 2007, 56 (7) :1761-1772.
|
|
[8]Tilg H.The Role of Cytokines in non-alcoholic fatty liver dis-ease[J].Dig Dis, 2010, 28 (1) :179-185.
|
|
[9]Adler M, Taylor S, Ckebugeu K, et al.Intrahepatic natural killerT cell populations are increased in human hepatic steatosis[J].World J Gastroenterol, 2011, 17 (13) :1725-1731.
|
|
[10]Maher JJ, Leon P, Ryan JC.Beyond insulin resistance:In-nate immunity in non-alcoholic steatohepatitis[J].Hepatol-ogy, 2008, 48 (2) :670-678.
|
|
[11]Kremer M, Thomas E, Milton RJ, et al.Kupffer cell and In-terleukin-12-Dependent loss of nature killer T cell in hepa-tosteatosis[J].Hepatology, 2010, 51 (1) :130-141.
|
|
[12]Ma X, Hua J, Li Z.Probiotics improve high fat diet-inducedhepatic steatosis and insulin by increasing hepatic NKT cells[J].Hepatology, 2008, 49 (5) :821-830.
|
|
[13]Kahraman A, Schlattjan M, Kocabayoglu P, et al.Major his-to-compatibility complex class I-related chains A and B (MIC A/B) :a novel role in nonalcoholic steatohepatitis[J].Hepatology, 2010, 51 (1) :92-102.
|
|
[14]Rada eva S, Sun R, Jaruga B, et al.Natural killer cells amel-iorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners[J].Gastroenterology, 2006, 130 (2) :435-452.
|
|
[15]Jeong WI, Gao B.Innate immunity and alcoholic liver fibrosis[J].J Gastroenterol Hepatol, 2008, 23 (1) :S112-S118.
|
|
[16]Rensen S, Slaats Y, Driesen A, et al.Activation of the com-plement system in human nonalcoholic fatty liver disease[J].Hepatology, 2009, 50 (6) :1809-1817.
|
|
[17]Yu H, Yang Y, Zhang M, et al.Thyroid status influence onAdiponectin, acylation stimulation protein (ASP) and comple-ment C3 in hyperthyroid and hypothyroid subject[J].NutrMetab, 2006, 3:13.
|
|
[18]Yesilova Z, Ozata M, Oktenli C, et al.Increased acylationstimulating protein concentrations in nonalcoholic fatty liverdisease are associated with insulin resistence[J].Am JGastroenterol, 2005, 100 (4) :842-849.
|
|
[19]Hillebrandt S, Wasmuth HE, Weiskirchen R, et al.Comple-ment factor 5 is a quantitative trait gene that modifies liver fi-brogenesis in miceandhumans[J].Nat Genet, 2005, 37 (8) :835-843.
|
|
[20]Wang Y, Yang YX.Advances in understanding the role ofcomplement in the pathogenesis of fatty liver disease[J].World J Dig, 2010, 18 (15) :1577-1581.
|
|
[21]Winer S, Chan Y, Paltser G, et al.Normalization of obeisity-associated insulin resistance throgh immunotherapy[J].Nat med, 2009, 15 (8) :921-929.
|
|
[22]Ma X, Hua J, Mohamood AR, et al.A High-Fat Diet andRegulatory T cell influence susceptibility to endotoxin-in-duced liver injury[J].Hepatology, 2007, 46:1519-1529.
|
|
[23]Sakaguchi S, Yamaguchi T, Nomura T, et al.Regulatory T celland immune tolerance[J].Cell, 2008, 5 (9) :775-787.
|
|
[24]Federico A, Aiuto ED, Borriello F, et al.Fat:A matter ofdisturbance for the immune system[J].World J Gastroen-terol, 2010, 16 (38) :4762-4772.
|
|
[25]Ogura H, Murakani M, Okuyama Y, et al.Interleukin-17promotes autoimmunity by triggering a positive-feedbackloop via interleukin-6 induction[J].Immunity, 2008, 29 (4) :628-636.
|
|
[26]Shi PQ, Zhu S, Qian YC.IL-17 signaling and function[J].Chinese Journal of cell Biology, 2011, 33 (4) :345-357.
|
|
[27]Tang Y, Bian Z, Zhao L, et al.Interleukin-17 exacerbates he-patic steatosis and inflammation in non-alcoholic fatty liver dis-ease[J].Clin EXP Immunol, 2011, 166 (2) :281-290.
|
|
[28]Starley BQ, Calcagno CJ, Harrison SA.Nonalcoholic fatty liv-er disease and hepatocellular carcinoma:a weighty connec-tion[J].Hepatology, 2010, 51 (5) :1820-1832. (本文编辑:王莹
|
DownLoad: